Relugolix Combination Therapy To Improve Quality Of Life In Fibroid Patients Overview This analysis aimed to assess the impact of 52 weeks of treatment with relugolix combination therapy (consisting of relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) on symptoms of uterine fibroids (UF) and quality of life (QoL) in
Tag: women’s health
Exploring Better Therapies For Polycystic Ovary Syndrome: The Role Of Anti-Obesity Medications
Exploring Better Therapies For Polycystic Ovary Syndrome: The Role Of Anti-Obesity Medications Overview This systematic review and meta-analysis aimed to assess the efficacy of anti-obesity agents in addressing hormonal, reproductive, metabolic, and psychological outcomes in women with polycystic ovary syndrome (PCOS), with the objective of informing updates to the International Evidence-based Guideline
Prenatal Gingivitis Prevalence In A Clinical Trial Exploring Oral Hygiene Education
Prenatal Gingivitis Prevalence In A Clinical Trial Exploring Oral Hygiene Education Overview Gingivitis is a very common oral condition affecting adults today. A major cause of gingivitis is dental plaque, which is often associated with poor oral brushing and/or flossing habits. Hormonal changes and some other factors have also been observed to
Bone Mineral Density Screening Combined with Mammogram
Improving Bone Mineral Density Screening by Using Digital X-Radiogrammetry (DXR) Combined With Mammography Bone Mineral Density: THE STUDY Osteoporosis is often underdiagnosed and undertreated, especially in women. In Australia, 2 in 5 women aged 50 or over will experience fragility fractures. Fractures associated with reduced bone mineral density (BMD) may cause disability
bone mineral density in type 1 diabetes mellitus
bone mineral density in type 1 diabetes mellitus The Study Bone mineral density of patients suffering from type 1 diabetes mellitus is often reduced due to impaired insulin secretion. However, it is unclear whether the rate of bone mineral density reduction is affected by the type 1 diabetes mellitus subtype. The objective
Obesity Screening to Predict Hot Flashes
Obesity Screening to Predict Hot Flashes Vasomotor symptoms (VMS) include hot flashes and night sweats. They are the primary symptoms of menopause and affect 60-80% of women. These symptoms all lead to a reduction in the quality of life. Contrary to the previous belief that VMS occurs near the final menstrual period
